Investigating Vortex Liquid Chromatography: An HPLC Interview with Wim De Malsche
At HPLC 2023, LCGC spoke with Wim De Malsche of Vrjie Universiteit Brussel in Brussels, Belgium. These clips comprise one of several HPLC interviews that were conducted at the conference.
De Malsche spoke with us at HPLC 2023 in Dusseldorf, Germany on the topic of his talk at the conference, "Exploring the separation potential of vortex liquid chromatography."
De Malsche is a Professor at Vrjie Universiteit Brussel in Brussels, Belgium.
In these interview clips, De Malsche answers the following:
1. What is vortex liquid chromatography? (00:17–01:41)
2. What benefits could vortex liquid chromatography offer? (01:42–02:28)
3. What aspects of vortex liquid chromatography have you explored? (02:29–03:54)
4. What are the next steps in your research? (03:55–05:26)
This interview was one of several conducted at HPLC 2023. You can see our latest conference coverage, including our additional video interviews conducted at HPLC, at the following link: https://www.chromatographyonline.com/conferences/hplc
SPE-Based Method for Detecting Harmful Textile Residues
January 14th 2025University of Valencia scientists recently developed a method using solid-phase extraction (SPE) followed by high-performance liquid chromatography coupled to high-resolution mass spectrometry (HPLC–HRMS/MS) for detecting microplastics and other harmful substances in textiles.
PFAS Analysis in Practice: A RAFA 2024 Interview with Stefan van Leuwen
January 10th 2025At the Recent Advances in Food Analysis (RAFA) conference in 2024, LCGC International sat down with Stefan van Leuwen of Wageningen Food Safety Research to discuss his research, which addresses emerging challenges in circular food production, focusing on the risks posed by pollutants when waste and by-products are repurposed in food systems.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
